PST3.1a
PST3.1a is a N-acetylglucosamine glycosyltransferase (MGAT5) inhibitor with the IC50 of 2 μM. PST3.1a inhibits glioblastoma-initiating cell invasiveness and proliferation[1].
Product Specifications
CAS Number
[1096144-06-7]
UNSPSC
12352005
Target
Glycosyltransferase
Related Pathways
Epigenetics
Field of Research
Cancer
Smiles
O[C@@H]([P@@](O[C@@H]1COCC2=CC=CC=C2)(C3=CC=CC=C3)=O)[C@@H](OCC4=CC=CC=C4)[C@@H]1OCC5=CC=CC=C5
Molecular Formula
C32H33O6P
Molecular Weight
544.57
References & Citations
[1]Hassani Z, et al. Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation. Mol Cancer Res. 2017;15 (10) :1376-1387.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163121/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15203661 1 Vial
Lentiviral mouse Adamts8 shRNA (UAS) - Lentiviral mouse Adamts8 shRNA (UAS, GFP) (100)
Ask
View Details 
![Rabbit Polyclonal ULK4 Antibody [Janelia Fluor 646]](https://cdn.genprice.uk/genprice/genprice4.png)